Home Recalls D-0109-2022
Class II · Moderate risk Terminated Initiated Oct 12, 2021 (5 years ago)
CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of assurance of sterility
What was recalled
CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Recalling firm Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Origin TX, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0109-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Terminated Apr 5, 2022
Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products…
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Completed Jul 9, 2021
Reason Lack of Assurance of Sterility